Contact
Please use this form to send email to PR contact of this press release:
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain
TO:
Please use this form to send email to PR contact of this press release:
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain
TO: